advocacy groups and providers have complained that patients
are having trouble obtaining intravenous immune globulin
services (HCPCS codes Q9941-Q9944) due to low rates, the
Centers for Medicare and Medicaid Services notes in its
latest drug price information.
Food and Drug Administration hasn't identified a shortage
of IVIG, and manufacturers say they have plenty available.
But CMS admits that access to IVIG is an important health
issue, and the agency promises to monitor availability.
For the third quarter of 2005, CMS is raising the payment
amount for the powdered form of lyophilized IVIG by 9 percent.